Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

52 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Frequent mutations in the mitochondrial control region DNA in breast tissue.
Rosson D, Keshgegian AA. Rosson D, et al. Among authors: keshgegian aa. Cancer Lett. 2004 Nov 8;215(1):89-94. doi: 10.1016/j.canlet.2004.04.030. Cancer Lett. 2004. PMID: 15374637
Lack of correlation between serum levels of E- and P-cadherin fragments and the presence of breast cancer.
Knudsen KA, Lin CY, Johnson KR, Wheelock MJ, Keshgegian AA, Soler AP. Knudsen KA, et al. Among authors: keshgegian aa. Hum Pathol. 2000 Aug;31(8):961-5. doi: 10.1053/hupa.2000.9074. Hum Pathol. 2000. PMID: 10987257
P-cadherin expression in breast carcinoma indicates poor survival.
Peralta Soler A, Knudsen KA, Salazar H, Han AC, Keshgegian AA. Peralta Soler A, et al. Among authors: keshgegian aa. Cancer. 1999 Oct 1;86(7):1263-72. doi: 10.1002/(sici)1097-0142(19991001)86:7<1263::aid-cncr23>3.3.co;2-u. Cancer. 1999. PMID: 10506713
Bcl-2 oncoprotein positivity and high MIB-1 (Ki-67) proliferative rate are independent predictive markers for recurrence in prostate carcinoma.
Keshgegian AA, Johnston E, Cnaan A. Keshgegian AA, et al. Am J Clin Pathol. 1998 Oct;110(4):443-9. doi: 10.1093/ajcp/110.4.443. Am J Clin Pathol. 1998. PMID: 9763029
erbB-2 oncoprotein expression in breast carcinoma. Poor prognosis associated with high degree of cytoplasmic positivity using CB-11 antibody.
Keshgegian AA, Cnaan A. Keshgegian AA, et al. Am J Clin Pathol. 1997 Oct;108(4):456-63. doi: 10.1093/ajcp/108.4.456. Am J Clin Pathol. 1997. PMID: 9322600
Expression of P-cadherin identifies prostate-specific-antigen-negative cells in epithelial tissues of male sexual accessory organs and in prostatic carcinomas. Implications for prostate cancer biology.
Soler AP, Harner GD, Knudsen KA, McBrearty FX, Grujic E, Salazar H, Han AC, Keshgegian AA. Soler AP, et al. Among authors: keshgegian aa. Am J Pathol. 1997 Aug;151(2):471-8. Am J Pathol. 1997. PMID: 9250159 Free PMC article.
Estrogen receptor-negative, progesterone receptor-positive breast carcinoma: poor clinical outcome.
Keshgegian AA, Cnaan A. Keshgegian AA, et al. Arch Pathol Lab Med. 1996 Oct;120(10):970-3. Arch Pathol Lab Med. 1996. PMID: 12046611
Proliferation markers in breast carcinoma.
Keshgegian AA, Cnaan A. Keshgegian AA, et al. Am J Clin Pathol. 1996 Jul;106(1):155. doi: 10.1093/ajcp/106.1.155. Am J Clin Pathol. 1996. PMID: 8701924 No abstract available.
ErbB-2 oncoprotein overexpression in breast carcinoma: inverse correlation with biochemically- and immunohistochemically-determined hormone receptors.
Keshgegian AA. Keshgegian AA. Breast Cancer Res Treat. 1995 Aug;35(2):201-10. doi: 10.1007/BF00668210. Breast Cancer Res Treat. 1995. PMID: 7647342
Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1.
Keshgegian AA, Cnaan A. Keshgegian AA, et al. Am J Clin Pathol. 1995 Jul;104(1):42-9. doi: 10.1093/ajcp/104.1.42. Am J Clin Pathol. 1995. PMID: 7611179
52 results
Jump to page
Feedback